Castle Biosciences, Inc. · NASDAQ:CSTL
The Vanguard Group reported a 6.54% stake in Castle Biosciences, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Jan 30, 2025
The Vanguard Group reported a 6.54% stake in Castle Biosciences, Inc., 1,832,535 shares, as a passive investor on Dec 31, 2024. Filed Jan 30, 2025 (Schedule 13G/A).
- Stake
- 6.54%
- Shares
- 1,832,535
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 6.54% | 1,832,535 |
Source
Related
- Castle Biosciences, Inc.
- The Vanguard Group
- Castle Biosciences, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · Maetzold Derek J · Oct 21, 2026
- Form 4 · Juvenal Tobin W · Oct 14, 2026
- Form 4 · Maetzold Derek J · Oct 7, 2026
- Form 4 · Oelschlager Kristen M · Oct 5, 2026
- Form 4 · Juvenal Tobin W · Oct 1, 2026